GlassScriptPhysician profile
Vishaal Gupta
NPI 1245894955
$1,306.26
in general payments reported to CMS, 2019-2025
15 companies · $1,018 in 2025
The $1,018 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $13.99 · 2022: $50.84 · 2024: $223 · 2025: $1,018.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,241.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $368.33 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Dexcom, INC. | $190.59 | 2025 | Dexcom G6 Transmitter |
| Ascendis Pharma Endocrinology INC | $94.22 | 2025 | Yorvipath |
| Novo Nordisk INC | $86.27 | 2024-2025 | Ozempic, Rybelsus, Sogroya |
| Sequel Med Tech, LLC | $85.04 | 2025 | Twiist |
| Boehringer Ingelheim Pharmaceuticals, INC. | $83.69 | 2025 | Jardiance |
| Lilly USA, LLC | $73.29 | 2025 | Mounjaro, Zepbound |
| Medtronic, INC. | $61.25 | 2024-2025 | Minimed 780g, Intellis Adaptivestim |
| Amgen INC. | $50.84 | 2022 | |
| Sanofi-Aventis U.S. LLC | $45.75 | 2024 | |
| Kyowa Kirin, INC. | $45.60 | 2024 | Crysvita |
| Abbott Laboratories | $43.04 | 2025 | Freestyle Libre 3 |
| Recordati_rare_diseases_inc. | $38.62 | 2024 | Isturisa, Signifor Lar |
| Xeris Pharmaceuticals, INC. | $25.74 | 2024 | Recorlev |
| Abbvie INC. | $13.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vishaal Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.